Wednesday, December 18, 2024
Home Client Page 36

Client

    Latest
    Internet Stock Review

    Institutional Analyst Newsletters. March.

    Client Editor / Curator -
    Internet | Biotech | Beverages | Marijuana | Blockchain The Institutional Analyst newsletter aggregates headlines from all our...

    Real Estate Wonder Redefy to go Public. Full-Service Real Estate Transactions for $3,500 Flat...

    Traveltech Editor / Curator -
    Redefy Holdings, Inc., Enters into Definitive Share Exchange Agreement to Become a Publicly Traded Company DENVER, March 12,...

    HealthLynked (HLYK) Prepares For Future UpListing to the NASDAQ Capital Market.

    All News Editor / Curator -
    NAPLES, Fla., March 04, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp. ("HealthLynked" or the "Company") (OTCQB: HLYK), is pleased to announce that the Company has...
    biotech stock review, dyadic

    Must Watch Video: Dyadic’s (DYAI) Matthew Jones.

    Client Editor / Curator -
    Click here to watch the video. It's the proverbial, "everything you wanted to know" about Cho...

    Internet Stock Review Initiates Coverage On HealthLynked Corp. (HLYK) $0.23.

    eCommerce Editor / Curator -
    NAPLES, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced it has retained Institutional Analyst Inc., to provide coverage...

    Added to Watch List $1.32, Dyadic Inc (DYAI) Announces $5 Million Stock Buyback.

    Biotech News Editor / Curator -
    CLICK TO VIEW REPORT
    Biotech Stock Review, Dicerna DRNA

    Adding Dicerna (DRNA) $3.30 to Watch List.

    Biotech News Editor / Curator -
    Adding Dicerna (DRNA) $3.30 to Watch List. How fun would it be to sell a $3.00 idea (IMMU) at...
    Biotech Stock Review

    Adding Immunomedics (IMMU) $3.00 to Watch List.

    Research Editor / Curator -
    Biotech Stock Review Initiates Coverage. Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears.
    Roland Rick Perry, Biotech Stock Review

    CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground Running.

    Biotech News Editor / Curator -
    “Announces Partnership With Caron Foundation, Ranked Amongst Top 7 Treatment Centers in US with Revenues Approaching $100 million.”
    video

    Zestra® Female Sexual Arousal on ABC’s “The View.”

    Video Editor / Curator -
    1...353637Page 36 of 37

    Latest article

    Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.

    All News Editor / Curator -
    119% Gain Post Split

    Nine Page Summary Report on GeoVax (GOVX)

    Client Editor / Curator -
    This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

    GeoVax (GOVX) Provides First Half 2024 Business Update.

    Client Editor / Curator -
    Award of BARDA Project NextGen contract represents a significant milestone event; Total value...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.